Media coverage
25
Media coverage
Title Abivax to host KOL Investor Event to review phase 2b clinical data and phase 3 trial design for obefazimod in patients with moderately to severely active ulcerative colitis on February 6, 2024 Media name/outlet Street Insider Country/Territory United States Date 24/01/24 URL https://www.streetinsider.com/Globe+Newswire/Abivax+to+host+KOL+Investor+Event+to+review+phase+2b+clinical+data+and+phase+3+trial+design+for+obefazimod+in+patients+with+moderately+to+severely+active+ulcerative+colitis+on+February+6%2C+2024/22664343.html Persons Marla Dubinsky Title Abivax To Host KOL Investor Event To Review Phase 2B Clinical Data And Phase 3 Trial Design For Obefazimod In Patients With Moderately To Severely Active Ulcerative Colitis On February 6, 2024 Media name/outlet MENAFN -Press Releases (English) Country/Territory Jordan Date 24/01/24 Persons Marla Dubinsky Title Abivax to host KOL Investor Event to review phase 2b clinical data and phase 3 trial design for obefazimod in patients with moderately to severely active ulcerative colitis on February 6, 2024 Media name/outlet PharmiWeb Country/Territory United Kingdom Date 24/01/24 URL https://www.pharmiweb.com/press-release/2024-01-24/abivax-to-host-kol-investor-event-to-review-phase-2b-clinical-data-and-phase-3-trial-design-for-obef Persons Marla Dubinsky Title Abivax to host KOL Investor Event to review phase 2b clinical data and phase 3 trial design for obefazimod in patients with moderately to severely active ulcerative colitis on February 6, 2024 Media name/outlet BioSpace Country/Territory United States Date 24/01/24 URL https://www.biospace.com/article/releases/abivax-to-host-kol-investor-event-to-review-phase-2b-clinical-data-and-phase-3-trial-design-for-obefazimod-in-patients-with-moderately-to-severely-active-ulcerative-colitis-on-february-6-2024/ Persons Marla Dubinsky Title Abivax to host KOL Investor Event to review phase 2b clinical data and phase 3 trial design for obefazimod in patients with moderately to severely active ulcerative colitis on February 6, 2024 Media name/outlet InvestorsObserver Country/Territory United States Date 24/01/24 URL https://www.investorsobserver.com/news/qm-pr/7884695093095439 Persons Marla Dubinsky Title Abivax to host KOL Investor Event to review phase 2b clinical data and phase 3 trial design for obefazimod in patients with moderately to severely active ulcerative colitis on February 6, 2024 Media name/outlet Yahoo! Finanzas Country/Territory United States Date 24/01/24 URL https://es-us.finanzas.yahoo.com/news/abivax-host-kol-investor-event-073000925.html Persons Marla Dubinsky Title Abivax to host KOL Investor Event to review phase 2b clinical data and phase 3 trial design for obefazimod in patients with moderately to severely active ulcerative colitis on February 6, 2024 Media name/outlet Yahoo! Finance Country/Territory United States Date 24/01/24 URL https://finance.yahoo.com/news/abivax-host-kol-investor-event-073000925.html Persons Marla Dubinsky Title Abivax to host KOL Investor Event to review phase 2b clinical data and phase 3 trial design for obefazimod in patients with moderately to severely active ulcerative colitis on February 6, 2024 Media name/outlet ADVFN US Country/Territory United States Date 24/01/24 URL https://www.advfn.com/stock-market/stock-news/93121799/abivax-to-host-kol-investor-event-to-review-phase-2b-clinical-data-and-phase-3-t Persons Marla Dubinsky Title EQS-News: Abivax to host KOL Investor Event to review phase 2b clinical data and phase 3 trial design for obefazimod in patients with moderately to severely active ulcerative colitis on February 6, 2024 Media name/outlet WebDisclosure.com Country/Territory Germany Date 24/01/24 URL https://www.webdisclosure.com/finance/stocks/abivax/news/1222625.html Persons Marla Dubinsky Title Abivax to host KOL Investor Event to review phase 2b clinical data and phase 3 trial design for obefazimod in patients with moderately to Media name/outlet LaGrange Daily News Country/Territory Georgia Date 24/01/24 URL https://smb.lagrangenews.com/article/Abivax-to-host-KOL-Investor-Event-to-review-phase-2b-clinical-data-and-phase-3-trial-design-for-obefazimod-in-patients-with-moderately-to-severely-active-ulcerative-colitis-on-February-6-2024?storyId=65b0bd5ab1186d4bf8dde71b Persons Marla Dubinsky Title Abivax to host KOL Investor Event to review phase 2b clinical data and phase 3 trial design for obefazimod in patients with moderately to Media name/outlet Holliston - Local Town Pages Country/Territory United States Date 24/01/24 URL https://pr.hollistontownnews.com/article/Abivax-to-host-KOL-Investor-Event-to-review-phase-2b-clinical-data-and-phase-3-trial-design-for-obefazimod-in-patients-with-moderately-to-severely-active-ulcerative-colitis-on-February-6-2024?storyId=65b0bd5ab1186d4bf8dde71b Persons Marla Dubinsky Title Abivax to host KOL Investor Event to review phase 2b clinical data and phase 3 trial design for obefazimod in patients with moderately to Media name/outlet Jessamine Journal Country/Territory United States Date 24/01/24 URL https://smb.jessaminejournal.com/article/Abivax-to-host-KOL-Investor-Event-to-review-phase-2b-clinical-data-and-phase-3-trial-design-for-obefazimod-in-patients-with-moderately-to-severely-active-ulcerative-colitis-on-February-6-2024?storyId=65b0bd5ab1186d4bf8dde71b Persons Marla Dubinsky Title Abivax to host KOL Investor Event to review phase 2b clinical data and phase 3 trial design for obefazimod in patients with moderately to... Media name/outlet Smithfield Times Country/Territory United States Date 24/01/24 URL https://smb.smithfieldtimes.com/article/Abivax-to-host-KOL-Investor-Event-to-review-phase-2b-clinical-data-and-phase-3-trial-design-for-obefazimod-in-patients-with-moderately-to-severely-active-ulcerative-colitis-on-February-6-2024?storyId=65b0bd5ab1186d4bf8dde71b Persons Marla Dubinsky Title Abivax to host KOL Investor Event to review phase 2b clinical data and phase 3 trial design for obefazimod in patients with moderately to Media name/outlet Luverne Journal Country/Territory United States Date 24/01/24 URL https://smb.luvernejournal.com/article/Abivax-to-host-KOL-Investor-Event-to-review-phase-2b-clinical-data-and-phase-3-trial-design-for-obefazimod-in-patients-with-moderately-to-severely-active-ulcerative-colitis-on-February-6-2024?storyId=65b0bd5ab1186d4bf8dde71b Persons Marla Dubinsky Title Abivax to host KOL Investor Event to review phase 2b clinical data and phase 3 trial design for obefazimod in patients with moderately to Media name/outlet Kenbridge Victoria Dispatch Country/Territory United States Date 24/01/24 URL https://smb.kenbridgevictoriadispatch.com/article/Abivax-to-host-KOL-Investor-Event-to-review-phase-2b-clinical-data-and-phase-3-trial-design-for-obefazimod-in-patients-with-moderately-to-severely-active-ulcerative-colitis-on-February-6-2024?storyId=65b0bd5ab1186d4bf8dde71b Persons Marla Dubinsky Title Abivax to host KOL Investor Event to review phase 2b clinical data and phase 3 trial design for obefazimod in patients with moderately to Media name/outlet Suffolk News Herald Country/Territory United States Date 24/01/24 URL https://smb.suffolknewsherald.com/article/Abivax-to-host-KOL-Investor-Event-to-review-phase-2b-clinical-data-and-phase-3-trial-design-for-obefazimod-in-patients-with-moderately-to-severely-active-ulcerative-colitis-on-February-6-2024?storyId=65b0bd5ab1186d4bf8dde71b Persons Marla Dubinsky Title Abivax to host KOL Investor Event to review phase 2b clinical data and phase 3 trial design for obefazimod in patients with moderately to Media name/outlet Elizabethton.com Country/Territory United States Date 24/01/24 URL https://smb.elizabethton.com/article/Abivax-to-host-KOL-Investor-Event-to-review-phase-2b-clinical-data-and-phase-3-trial-design-for-obefazimod-in-patients-with-moderately-to-severely-active-ulcerative-colitis-on-February-6-2024?storyId=65b0bd5ab1186d4bf8dde71b Persons Marla Dubinsky Title Abivax to host KOL Investor Event to review phase 2b clinical data and phase 3 trial design for obefazimod in patients with moderately to Media name/outlet Winchester Sun Country/Territory United States Date 24/01/24 URL https://smb.winchestersun.com/article/Abivax-to-host-KOL-Investor-Event-to-review-phase-2b-clinical-data-and-phase-3-trial-design-for-obefazimod-in-patients-with-moderately-to-severely-active-ulcerative-colitis-on-February-6-2024?storyId=65b0bd5ab1186d4bf8dde71b Persons Marla Dubinsky Title Abivax to host KOL Investor Event to review phase 2b clinical data and phase 3 trial design for obefazimod in patients with moderately to Media name/outlet TheTidewaterNews.com Country/Territory United States Date 24/01/24 URL https://smb.thetidewaternews.com/article/Abivax-to-host-KOL-Investor-Event-to-review-phase-2b-clinical-data-and-phase-3-trial-design-for-obefazimod-in-patients-with-moderately-to-severely-active-ulcerative-colitis-on-February-6-2024?storyId=65b0bd5ab1186d4bf8dde71b Persons Marla Dubinsky Title Abivax to host KOL Investor Event to review phase 2b clinical data and phase 3 trial design for obefazimod in patients with moderately to Media name/outlet Port Arthur News Country/Territory United States Date 24/01/24 URL https://smb.panews.com/article/Abivax-to-host-KOL-Investor-Event-to-review-phase-2b-clinical-data-and-phase-3-trial-design-for-obefazimod-in-patients-with-moderately-to-severely-active-ulcerative-colitis-on-February-6-2024?storyId=65b0bd5ab1186d4bf8dde71b Persons Marla Dubinsky Title Abivax to host KOL Investor Event to review phase 2b clinical data and phase 3 trial design for obefazimod in patients with moderately to Media name/outlet L' Observateur Country/Territory United States Date 24/01/24 URL https://smb.lobservateur.com/article/Abivax-to-host-KOL-Investor-Event-to-review-phase-2b-clinical-data-and-phase-3-trial-design-for-obefazimod-in-patients-with-moderately-to-severely-active-ulcerative-colitis-on-February-6-2024?storyId=65b0bd5ab1186d4bf8dde71b Persons Marla Dubinsky Title Abivax to host KOL Investor Event to review phase 2b clinical data and phase 3 trial design for obefazimod in patients with moderately to Media name/outlet Tryon Daily Bulletin Country/Territory United States Date 24/01/24 URL https://smb.tryondailybulletin.com/article/Abivax-to-host-KOL-Investor-Event-to-review-phase-2b-clinical-data-and-phase-3-trial-design-for-obefazimod-in-patients-with-moderately-to-severely-active-ulcerative-colitis-on-February-6-2024?storyId=65b0bd5ab1186d4bf8dde71b Persons Marla Dubinsky Title EQS-News: Abivax to host KOL Investor Event to review phase 2b clinical data and phase 3 trial design for obefazimod in patients with moderately to severely active ulcerative colitis on February 6, 2024 Media name/outlet EQS Newsfeed (English) Country/Territory Germany Date 24/01/24 Persons Marla Dubinsky Title Abivax to host KOL Investor Event to review phase 2b clinical data and phase 3 trial design for obefazimod in patients with moderately to severely active ulcerative colitis on February 6, 2024 Media name/outlet 96.7 3WZ-FM Country/Territory United States Date 24/01/24 URL https://lifestyle.3wzfm.com/story/50374048/abivax-to-host-kol-investor-event-to-review-phase-2b-clinical-data-and-phase-3-trial-design-for-obefazimod-in-patients-with-moderately-to-severely Persons Marla Dubinsky Title Abivax to host KOL Investor Event to review phase 2b clinical data and phase 3 trial design for obefazimod in patients with moderately to severely active ulcerative colitis on February 6, 2024 Media name/outlet GlobeNewswire Country/Territory United States Date 24/01/24 Persons Marla Dubinsky